Relevance of the GH-VEGFB/VEGFA axis in liver grafts from brain-dead donors with alcohol-associated liver disease by Marc Micó-Carnero, Marc Micó-Carnero, Carlos Rojano-Alfonso, Carlos Rojano-Alfonso, Cristina Maroto-Serrat, Cristina Maroto-Serrat, Juan Carlos Cutrin, Araní Casillas-Ramírez, Araní Casillas-Ramírez, Carmen Peralta

“…IntroductionGrafts with alcohol-associated liver disease (ALD) subjected to prolonged cold ischaemia from donors after brain death (DBD) are typically unsuitable for transplantation. …”
Get full text

Suppression of IRE1α Attenuated the Fatty Degeneration in Parenteral Nutrition-Related Liver Disease (PNALD) Cell Model by Ningxun Cui, Mingling Cui, Jie Li, Xueping Zhu, Xiaoli Zhu

“…To model the parenteral nutrition-associated liver disease (PNALD) in rat normal hepatocytes BRL and investigate the role of endoplasmic reticulum stress- (ERS-) related IRE1α signal in the process of PNALD. …”
Get full text

Higher risk of carotid plaque among lean individuals with non-alcoholic fatty liver disease: A retrospective study. by Jiangfeng Xue, Lun Zhao, Liang Shao, Huiwang Zhang, Yewei Feng, Ping Shuai

“…<h4>Background</h4>Lean individual with non-alcoholic fatty liver disease (L-NAFLD) is a prominent area of research, yet its pathogenesis and association with other diseases such as atherosclerotic cardiovascular disease remain uncertain.…”
Get full text

Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls by Justyna Kuliczkowska Plaksej, Lukasz Laczmanski, Andrzej Milewicz, A. Lenarcik-Kabza, Anna Trzmiel-Bira, Urszula Zaleska-Dorobisz, Felicja Lwow, Lidia Hirnle

“…Polycystic ovary syndrome (PCOS) is frequently associated with nonalcoholic fatty liver disease (NAFLD). The endocannabinoid system may play a crucial role in the pathogenesis of NAFLD. …”
Get full text

Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning by Chuan Lu, Mei Han, Qiqi Ma, Li Ying, Yue Zhang

Subjects: “…Non-alcoholic fatty liver disease…”
Get full text

Targeting Toll-like receptor 4 and microbiota dysregulation: a new frontier in nonalcoholic fatty liver disease management by K.B. Kvit

Subjects: “…nonalcoholic fatty liver disease…”
Get full text

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease by Dimitrios Patoulias, Maria Kalogirou

Get full text

von Willebrand factor polymorphism (rs1063856) as a risk factor for portal vein thrombosis in chronic liver diseases by Isis Samy Bedira, Olfat M. Hendy, Moones Abdelaal, Ashraf A. Basuni, Asma Ebrahim Gaber Koshoo, Alzhraa Alkhatib, Sally S. Mandour

Subjects: Get full text

Ferroptosis as a potential connection between schizophrenia and metabolic dysfunction-associated steatotic liver disease – a narrative review by Jakub Rogalski, Tomasz Tomczak

Get full text

Phenotypes of Non-Alcoholic Fatty Liver Disease in Different Regions of the Russian Federation, Diagnostic and Therapeutic Approach in Clinical Practice by V. T. Ivashkin, M. S. Zharkova, N. V. Korochanskaya, I. B. Khlynov, Yu. P. Uspensky

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals by Qian Zhang, Zhilong Liu, Jiaqi Zhang, Shangjie Yang, Liping Liu

“…Abstract Metabolic dysfunction associated fatty liver disease (MAFLD) is a prevalent liver condition and presents a major clinical and public health problem worldwide. …”
Get full text

Modern Approaches to Vaccination of Patients with Chronic Liver Diseases and Inflammatory Bowel Diseases against a Novel Coronavirus Infection by A. A. Sheptulin, V. T. Ivashkin

Subjects: “…сhronic liver disease…”
Get full text

Liver diseases (<i>Review of the Seventeenth Russian Gastroenterological Week proceedings, October, 10–12, 2011, Moscow</i>) by I. V. Mayev, A. N. Kazyulin, Yu. A. Kucheryavy, Ye. A. Mayevskaya

Subjects: “…liver diseases…”
Get full text

The Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation for the Management of Obesity and Non-Alcoholic Fatty Liver Disease: Recent Updates by Ruike Yan, Yanli Cao

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Design, Synthesis, and Biological Evaluation of Novel Pyrrolo [2,3-b] Pyridine Derivatives for Nonalcoholic Fatty Liver Disease by Jialin Ma, Jing Li, Dongping Yao, Qi Wang, Xinzhou Chen, Feiyan Tao, Bin Chen, Yongmei Xie, Lang Bai, Yiwen Zhang

“…Nonalcoholic fatty liver disease (NAFLD) is featured with liver fat infiltration and accumulation with no connection with overdrinking. …”
Get full text

Speculation of the Time-Dependent Change of FIB4 Index in Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Study by Hiroshi Miyata, Satoru Miyata

“…To speculate on the time-dependent change of FIB4 index in patients with nonalcoholic fatty liver disease (NAFLD) and its increase-decrease rate per year, simply and accurately. …”
Get full text

Noninvasive assessment of hepatic steatosis grades by ultrasound derived fat fraction in metabolic dysfunction associated steatotic liver disease by Meng Sun, Mingwei Zhong, Fangqiong Luo, Meng Lan, Xinru Zhang, Wei Nie, Zhe Ma

Get full text

Global perspectives and hotspots of VEGF signaling pathway in liver disease from 2008 to 2023: A bibliometric analysis and visualization by Yi He, Jiaxin Huang, Xiaofan Liang, Chang Shao, Xiguang Sun, Junjie Zhang

Subjects: Get full text

Increased Serum Angiotensin II Is a Risk Factor of Nonalcoholic Fatty Liver Disease: A Prospective Pilot Study by Yue Li, Feng Xiong, Wen Xu, Side Liu

“…Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases. …”
Get full text

Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults by Ya-Nan Zhang, Qin-Qiu Wang, Yi-Shu Chen, Chao Shen, Cheng-Fu Xu

“…The risk factors for nonalcoholic fatty liver disease (NAFLD) in lean population have not been fully clarified. …”
Get full text